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Expected mortality rates calculated from a reference population are used in occupational, actuarial, and medical research, and they are often used as a comparative measure for an exposed population of interest. In order for estimates that use this comparative measure to be unbiased, it is important that expected mortality rates represent the mortality the exposed population would have experienced had they been unexposed (1) (2) (3) (4) (5) (6) . Thus, when one wishes to compare different factors for which both the exposed population mortality and expected mortality rates vary, expected mortality rates stratified by such factors should be used. Here we focus on population-based cancer studies where expected mortality rates are often presented in life tables according to age, sex, and calendar year. Relative survival (7, 8) , the loss in expectation of life (9) , and standardized mortality ratios (SMRs) for cancers all use expected mortality as a proxy for the mortality rate cancer patients would have experienced had they been free of cancer. It is of interest to consider how risk factors other than age, sex, and calendar year affect cancer survival-for example, comorbidity or socioeconomic status (SES). Because both cancer-specific and all-cause mortality differ by SES (10, 11) , one must account for differences in mortality in the reference general population according to SES if one wishes to estimate relative survival or similar measures according to SES.
This problem has been addressed previously by creating stratified life tables using individualized information for the whole population (12) (13) (14) (15) (16) . Unfortunately, it may not always be possible to obtain information for such factors for the whole population. There have also been some attempts to address this problem for SMRs in a Bayesian framework using different prior distributions (17) . Others describe methods that create stratified life tables for such risk factors when individualized data are not available by using mortality information from subgroups of the reference population and prevalence of risk factors (4, 12, 18) . We expand on these methods by presenting two models that use information from a control population to adjust expected mortality rates for covariates other than age, sex, and calendar period. The methods described here require a control population that accurately represents the reference population. This could be either a control population for the disease of interest or another control population not related to the disease of interest. Using data on SES from a Swedish control population as an example, we also describe how to account for additional uncertainty involved in such methods by using parametric bootstrapping.
METHODS

Data
We used a cohort of breast cancer patients diagnosed between 1992 and 2012 in the Stockholm and Gotland regions of Sweden from a register-based database, BCBaSe, alongside matched controls; matching was based on age, year, and region. Information on highest educational level was available for women with breast cancer and controls and was used as a measure of SES. SES was categorized into low, medium, and high; these corresponded to compulsory education of up to 9 years, secondary education of up to 3 years, and postsecondary education, respectively. Data on the Swedish population, obtained from Statistics Sweden (19) , were used to create expected mortality rates specific to the Stockholm and Gotland regions by age and calendar year for women. Follow-up of women in the control group began 1 year after the diagnosis date of their matched breast cancer case to avoid a problem with the original matching that was based on the control participant being alive at the end of the year of diagnosis for the corresponding case participant. We restricted analyses to women with breast cancer who were diagnosed, and controls who started followup, between 35 and 90 years of age. The study was approved by the Stockholm Regional Ethics Review Board.
Relative survival
We were interested in modeling relative survival of the breast cancer patients in BCBaSe according to SES. Relative survival, ( ) R t , is defined as the ratio of the observed all-cause survival in the cancer patients, ( ) S t , and the survival expected had the cancer patients been cancer-free, *( ) S t ; the latter of these is commonly taken as the expected survival from the general population, and t represents time. We were interested in relative survival as an estimator of net survival, the survival experienced by patients when they can die only of their cancer (20) . Transforming the relative survival function to a hazard function gives the excess hazard (or excess mortality rate), λ( ) t . This is the difference between the all-cause mortality seen in the cancer patients, ( ) h t , and the mortality had the cancer patients been cancer-free, *( ) h t . It is generally preferable to model the hazard function, but it is straightforward to transform back to the survival scale. We were interested in estimating the relative survival for the breast cancer patients according to SES, age at diagnosis (a d ), and year of diagnosis (y d ) as a function of time since diagnosis (t):
Standardized mortality ratio
In addition to relative survival, we were interested in calculating the SES-specific SMR. The SMR is the ratio of the observed number of deaths in the study population divided by the expected number of deaths in the reference population while standardizing over important covariates; the denominator is calculated by multiplying the mortality rate in the reference population with the person-time at risk in the study population (21) . The reference population should represent the study population had they not been.
Methods to adjust expected mortality rates
We need *( | ) S t a y SES, , d d in order to estimate the relative survival by SES as written above. On the hazard scale, this means we need the expected morality rates stratified by SES, age, and year. Because from life tables we often have expected mortality rates only according to sex, age, and year, we were interested in estimating adjustment factors, ρ j , for each SES group j; these can be functions of attained age and attained year and are multiplied by the unadjusted mortality rate to give the SES-adjusted rate. The adjustment factors quantify the ratio between the mortality rate in the control population, h c , and the expected mortality rate in the whole population, * h , for each SES group. This can be formulated in the following way:
Two time scales, attained age a and attained year y, are included. We use modeling approaches to use all information and avoid potential problems with small control populations. Note that sex was omitted from models in this application because the control population contained only women. In this study, we used a control population that was matched to our cases of interest; however, the described methodology could have been undertaken using a separate control population, provided that the control population was representative of the reference population. Similarly, the resulting SES-adjusted expected mortality rates, calculated using the matched control population described here, could be used for analyses of diseases other than breast cancer.
Adjusting expected mortality rates using Poisson models. )) ln h a y , was included so that covariate coefficients modeled deviations from this offset.
In order to model 2 time scales using this approach, we split the time scale for every individual according to attained age and attained year. We split in monthly intervals, which increased the number of observations in our data set from 133,361 to 29,553,897; we included the log of the original unadjusted expected rate, (λ*( )) ln a y , , as an offset, which assumed a constant rate for each year. Splitting time in this way can become more computationally intensive with increasing numbers of time scales and for smaller time increments.
Adjusting expected mortality rates using flexible parametric survival models. Flexible parametric survival models (FPSMs) can also be used to adjust expected mortality rates. FPSMs (22) use restricted cubic splines (23) to model a transformation of the survival function. In this application, the models were used to model the log hazard function (24, 25) . A FPSM that models the log hazard function looks as follows:
where t is time, ( ( ) γ ) rcs ln t ; 0 is a restricted cubic spline function of log time, D is the number of covariates with time-dependent effects, and ( ( ) γ ) rcs ln t ; d is the spline function for the dth timedependent effect.
In order to use an FPSM to estimate adjustment factors, we must smooth expected mortality rates and constrain coefficients in the FPSM to ensure that there is no reference group represented by the baseline restricted cubic spline. This way covariate coefficients estimate deviations from the smoothed expected rate. Expected mortality rates in life tables are empirical calculations of the rate in every age between 0 and 100 in yearly increments. These rates can fluctuate from year to year, particularly when considering a specific region in a single country, as in this application. This reasoning can be another argument for smoothing the expected mortality rates found in life tables; smoothing is also useful when abridged life tables are available (26) . Smoothed expected mortality rates, * h s , were estimated by Poisson models using the number of deaths and person-time at risk from the original expected mortality rates, * d and * r respectively, in the following way: where attained age and attained year were modeled using restricted cubic spline functions rcs with 4 degrees of freedom.
Here we assume that the coefficient for age is the same within each attained year, however, it is possible to extend this model by including interactions. We use these smoothed expected mortality rates in FPSMs to estimate adjustment factors as follows: In both approaches, ρ j was allowed to vary over attained age in a smooth manner, but the covariate for calendar year was assumed to be constant (i.e., the coefficient for age was assumed to be the same over all calendar years); 2 degrees of freedom were used for the splines included in the interaction between attained age and SES. The functional form assumed for the adjustment factors is highly important and should be checked using standard model checking methods (i.e., using the Akaike information criterion and/or Bayesian information criterion) and likelihood ratio tests. Sensitivity analyses of the functional form assumed here are presented in Web Figures  1-3 (available at https://academic.oup.com/aje). Example Stata (StataCorp LP, College Station, Texas) code and data sets are also available in Web Appendix 1, illustrating how to estimate adjustment factors using the two approaches.
Uncertainty in adjusted expected mortality rates. It is common to assume that there is no uncertainty in the expected mortality rates taken from life tables, because these rates are usually based on the whole population. However, when creating adjusted expected mortality rates using a control population, there is uncertainty associated with the estimation of the adjustment factors that should be accounted for; this is a 2-step process where the uncertainty of the estimated adjustment factors is carried through to analyses that use the adjusted expected mortality rates. Accounting for this uncertainty can be done in the following way, using a parametric bootstrap method: 3. Create new adjusted mortality rates using these new adjustment factors. 4. Estimate relative survival and its variance using these new expected mortality rates. 5. Save these estimates and repeat steps 2-4 a number of times, n. 6. Estimate the adjusted standard error SE adjusted using Rubin's rules (27, 28) ,
where W is the mean of the variances estimated in each of the n bootstraps, and B is the variance of the relative survival estimates from the n bootstraps.
In this study, we used the above process with 100 repetitions, where relative survival was estimated from flexible parametric survival models as described in the next section, and the variance of the estimated relative survival was obtained using the delta method.
Relative survival and SMR analyses of Swedish breast cancer patients
Data from 26,913 breast cancer cases in women from BCBaSe were used to obtain estimates of SES-specific 5-year relative survival. FPSMs were used to model the log excess cumulative hazard with 3 degrees of freedom. These models adjusted for SES, both age at diagnosis and year of diagnosis, using restricted cubic splines with 2 degrees of freedom with knots placed at equally spaced quantiles of the distribution of the events, included timedependent effects for these 3 variables, and included an interaction between age at diagnosis and year of diagnosis. The expected mortality rates estimated from the unadjusted Swedish life table and SES-adjusted mortality rates by the methods described were used. We calculated confidence intervals for the relative survival estimates using a parametric bootstrap as described. We also calculated confidence intervals based on estimated adjustment factors, using 10% and 1% random samples of the control population, to assess how the confidence intervals varied using differentsized control populations. Point estimates of relative survival taken from these different sample sizes were not directly comparable because only 1 random sample was selected; we were interested only in how the uncertainty in the relative survival varied.
We also estimated SMRs for patients diagnosed with stage I breast cancer according to SES; stage I disease was chosen as an example in order to avoid presenting SMRs over all stages. We compared the SMRs when using the SES-adjusted and the original unadjusted expected mortality rates as the reference rate across several ages at diagnosis.
RESULTS
Descriptive statistics of the breast cancer cases and controls from the Stockholm and Gotland regions that were identified in the BCBaSe database and used in the analyses are shown in Table 1 . For 3.7% of controls and 3.2% of cases, SES data were missing (these data are not included in Table 1 ). Data from 133,361 female controls were used for the adjustment of expected mortality rates, and data from 26,913 women with breast cancer were used for relative survival analyses after exclusions based on age at diagnosis. Figure 1 shows the estimated adjustment factors and Figure 2 the adjusted mortality rates from the two approaches. The adjustment factors were slightly different in the two methods, particularly for those less than 50 years of age. Uncertainty was higher in the adjustment factors from both approaches where the mortality rates were smaller. Not surprisingly, the mortality rate for the high-SES group was lower than the original unadjusted mortality rate. While the adjusted mortality rate for the medium-SES group was similar to the unadjusted rate in those younger than 70 years, the adjusted mortality rate in the low-SES group was more similar to the unadjusted rate in those older than 70 years. Figure 2 also illustrates the consequence of smoothing in the FPSM approach. Figure 3 shows 5-year relative survival by SES estimated from FPSMs using the original unadjusted mortality rates from life tables and the SES-adjusted mortality rate from the FPSM approach. Similar results were seen for the Poisson model approach (shown in Web Figure 4 ). The relative survival was highest for the high-SES group for all ages when using both the unadjusted and SES-adjusted expected mortality rate. Using the unadjusted expected mortality rates suggested that there was a larger difference in the 5-year relative survival between the low-and high-SES groups. For example, the difference in the 5-year relative survival between the low-and high-SES groups when using unadjusted expected mortality rates in the year 2000 for patients aged 45 years at diagnosis ( Figure 3A ) was 0.0521; this difference was 0.0266 when using SES-adjusted rates from the FPSM. Table 2 displays SMRs using the unadjusted expected mortality rate as well as the SES-adjusted expected mortality rate using the Poisson approach and the FPSM approach. There is a clear difference between the SMRs when using the unadjusted and SES-adjusted expected rates.
Confidence intervals for 5-year relative survival were slightly widened due to the additional uncertainty of estimating the adjustment factors; see Figure 4 for high SES and Web Figures 5 and 6, respectively, for low and medium SES. Web Tables 1-6 show more detailed results for 1-, 5-, and 10-year relative survival. Figure 4 also shows confidence intervals for relative survival estimates when using 10% and 1% random samples of the control population. For those aged 45 years at diagnosis in year 2000 ( Figure 4A ), the 5-year relative survival was estimated at 0.9255 using adjusted expected mortality rates from the Poisson approach. The unadjusted and adjusted standard errors for this estimate were 0.0617 and 0.0635, respectively. Larger differences in the adjusted confidence interval were seen in older ages. For example, the 5-year relative survival estimated when using adjusted rates from the Poisson approach for women 75 years of age in 2000 was 0.8843, with corresponding unadjusted and adjusted standard errors of 0.0749 and 0.0801, respectively ( Figure 4D ). When using only random samples of 10% and 1% of the control population, confidence intervals widened further; the adjusted standard errors for 5-year relative survival when using 10% and 1% random samples were 0.0666 and 0.0955, respectively, for patients aged 45 years in 2000.
DISCUSSION
Our results showed that both the Poisson and FPSM approaches can be used to adjust expected mortality rates and create adjusted life tables. Results from both methods yielded a higher mortality rate in the low-SES group and a lower mortality rate in the high-SES group. Results from relative survival analyses indicated that differences in mortality rates between the SES groups tended to be overestimated if SES-adjusted expected mortality rates were not used. Our findings corroborate results from earlier studies of socioeconomic gradients in breast cancer survival in Sweden (29) (30) (31) and previous findings of bias in estimates that used life tables that were not adjusted for subgroups (4) (5) (6) . We found little difference in the size of confidence intervals when using a parametric bootstrap in a large control population. Using only 1% of the control population (approximately 1,400 individuals) to estimate adjustment factors resulted in larger confidence intervals. Because of higher all-cause mortality among the older women, there was a larger uncertainty in this group when estimating the adjustment factors, which translated into a wider confidence interval when accounting for this additional uncertainty. Any additional uncertainty in any relative survival estimates due to estimating adjustment factors may also reflect the complexity of the adjustment factors model. We expected the adjusted mortality rate for the low-SES group to be higher than the original unadjusted mortality rate. However, in women older than 70 years, the low-SES mortality rate was almost the same as the original unadjusted mortality rate; this similarity was due to a larger proportion of women this age being classified as low SES, particularly in earlier calendar years. This illustrates a potential problem of using educational level as a measure of SES-the opportunity to achieve a higher education was less common in earlier birth cohorts. Suitable and stable measures of SES for use in research have been discussed extensively elsewhere (32, 33) . It may have also been useful to include additional covariates and interactions in the model to account for the difference in highest education achieved over age and calendar year.
Both approaches for estimating adjustment factors are dependent on the control population being representative of the reference population (i.e., transportability characteristics must hold (34)). If the control population is not representative, then the adjusted mortality rates will be incorrect, and analyses using these will be biased. For example, it is not advisable to use a male control group to estimate adjustment factors for a female population because the association between SES and mortality may differ among men and women. However, it is possible for the adjustment factors estimated using the methods described here to be applied to different populations based on reasonable assumptions; for example, the adjustment factors estimated here for the Stockholm and Gotland regions are likely to be applicable to the whole of Sweden. In this illustration, a matched control population was used to estimate adjustment factors and adjusted expected mortality rates. It is important to note that the control population used in the estimation of the adjustment factors need not be a control population that was previously matched to the diseased population of interest. We saw minor differences in the adjustment factors and their confidence intervals between the Poisson and the FPSM approaches. The reason for these differences could be: 1) differences when considering continuous time, as in the FPSM approach, versus assuming a constant expected mortality within yearly intervals, as in the Poisson approach; or 2) the consequence of using smoothed rates plus the model chosen to smooth the expected mortality rates. It is possible to use the Poisson approach when using smoothed expected mortality rates, thus Model Figure 4 . Five-year relative survival estimates and 95% confidence intervals for high socioeconomic status among women in the Stockholm and Gotland regions of Sweden, in 2000, using the full control data set with unadjusted confidence intervals (n = 133,361; models 1 and 5), with adjusted confidence intervals (n = 133,361; models 2 and 6), using adjusted confidence intervals for a 10% random sample (n = 13,414; models 3 and 7), and adjusted confidence intervals for a 1% random sample (n = 1,394; models 4 and 8). Results are presented for ages at diagnosis of 45 years (A), 55 years (B), 65 years (C), and 75 years (D). we repeated analyses using this method and saw closer agreement between the adjustment factors estimated from this model and those estimated from the FPSM. However, small differences were seen in the absolute adjusted rates between the two methods because the largest differences in adjustment factors were seen for those younger than 50 years, among whom the absolute rate is very small. In the same manner, a possible limitation of the smoothing implemented in this study is that the model used was simple. While it is possible to use a more complex smoothed-rates model, sensitivity analyses illustrated that the smoothed-rates model offered a reasonable fit; Web Figure 1 shows the fit of different smoothed-rates models for the year 2000. On the other hand, it may not be reasonable to assume a constant expected mortality rate within a yearly period, and smoothing offers an alternative to this assumption. This work expands on previous work using SMRs to create subpopulation (or adjusted) expected mortality rates. These previous methods require information on the prevalence of exposures in the whole population (4, 18) or use covariate-specific SMRs (12) (e.g., for a specific age, year, and SES group). Although these methods also estimate adjusted expected mortality rates, our methods have additional advantages. First, information on the whole reference population is not required; we instead suggest using information often recorded in control populations, related or unrelated to the affected population, and making the assumption that the control population is representative of the reference population. Here, we assumed the stratified mortality rates (according to SES, age, and year) in the control population were representative of the reference population. Second, it is advantageous to use information from both the control population and the general (reference) population. Third, covariate-specific SMRs are usually available for categorized covariates, here we are able to capture a continuous function of covariates using a modeling framework.
In conclusion, both the Poisson and FPSM approaches can be used to adjust expected mortality rates using a control population; these adjusted rates are essential for avoiding biased results in certain situations when calculating relative survival, SMRs, and other similar measures. Because the Poisson model is a generalized linear model and available in different statistical software, it will be the more familiar approach to many. The ability to model 2 time scales simultaneously in the FPSM approach is highly useful to avoid long computational time when using a large data set. Accounting for the additional uncertainty involved in estimating adjustment factors using a control population can be done using parametric bootstrapping, and this should be done for small control populations, but it may not make a large difference when the control population is large. Because data on factors such as SES are often more easily available in control populations, the methodology presented in this study could offer the possibility of estimating relative survival, SMRs, and other measures to answer clinically relevant questions for risk factors other than sex, age, and calendar year of diagnosis.
